(Q44625295)

4 December 2017

title

An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems (English)

1 reference

4 December 2017

An Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune Systems (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

23 March 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

23 March 2024

1

Peggy P. Ho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568974

23 March 2024

4

Lawrence Steinman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568974

23 March 2024

author name string

Paulo Fontoura

2

1 reference

4 December 2017

Hideki Garren

5

1 reference

4 December 2017

Pedro J. Ruiz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568974

23 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

4 December 2017

published in

Journal of Immunology

1 reference

4 December 2017

volume

171

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

4920-4926

1 reference

Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

23 March 2024

2

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

23 March 2024

3

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

CpG motifs in bacterial DNA trigger direct B-cell activation

23 March 2024

5

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

23 March 2024

7

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences

23 March 2024

8

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

23 March 2024

9

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

A Toll-like receptor recognizes bacterial DNA

23 March 2024

10

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

23 March 2024

11

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

23 March 2024

12

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

CpG motifs in bacterial DNA and their immune effects

23 March 2024

13

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo

23 March 2024

16

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Non-coding plasmid DNA induces IFN-gamma in vivo and suppresses autoimmune encephalomyelitis

23 March 2024

18

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Clinical trials of interferons in multiple sclerosis. What have we learned?

23 March 2024

19

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway

23 March 2024

20

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis

23 March 2024

22

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice

23 March 2024

23

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Plasmid vaccination with insulin B chain prevents autoimmune diabetes in nonobese diabetic mice

23 March 2024

24

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Innate immunity: the virtues of a nonclonal system of recognition

23 March 2024

25

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

The instructive role of innate immunity in the acquired immune response

23 March 2024

26

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Innate immunity: impact on the adaptive immune response

23 March 2024

27

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Tolerance, danger, and the extended family

23 March 2024

28

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity

23 March 2024

29

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes

23 March 2024

30

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60

23 March 2024

31

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

23 March 2024

32

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

23 March 2024

33

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

23 March 2024

34

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis

23 March 2024

35

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

23 March 2024

36

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Mechanisms of effects of complement inhibition in murine collagen-induced arthritis

23 March 2024

37

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis

23 March 2024

38

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis

23 March 2024

39

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4920

23 March 2024

Identifiers

1 reference

4 December 2017

1 reference